Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE ACUTE CORONARY SYNDROME MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 SERVICES LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS FIVE FORCES
5 EUROPE ACUTE CORONARY SYNDROME MARKET: REGULATORY SCENARIO
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISE IN PREVALENCE OF CHRONIC DISEASES, SUCH AS CORONARY ARTERY DISEASE, ISCHEMIC HEART DISEASE, AND VASCULAR DISEASES
6.1.2 GROWING GERIATRIC POPULATION
6.1.3 WIDE RANGE OF PRODUCTS OFFERED BY MARKET PLAYERS
6.1.4 IMPROVING HEALTHCARE INFRASTRUCTURE AND REIMBURSEMENT POLICIES
6.2 RESTRAINTS
6.2.1 RISE IN COST OF THERAPEUTIC SURGERY
6.2.2 STRINGENT RULES & REGULATIONS
6.3 OPPORTUNITIES
6.3.1 SURGE IN TECHNOLOGICAL ADVANCEMENTS FOR CARDIOVASCULAR DISEASE
6.3.2 RISING HEALTHCARE EXPENDITURE
6.3.3 INCREASED REIMBURSEMENT POLICIES
6.3.4 RISING DISEASE MANAGEMENT PROGRAMS
6.4 CHALLENGES
6.4.1 LACK OF ACCESSIBILITY OF SERVICES
6.4.2 LONG PROCESS OF APPROVAL BY REGULATORY BODIES
7 EUROPE ACUTE CORONARY SYNDROME MARKET, BY TYPE
7.1 OVERVIEW
7.2 NON-ST- ELEVATION MYOCARDIAL INFARCTION
7.3 ST-ELEVATION MYOCARDIAL INFARCTION
7.4 UNSTABLE ANGINA
8 EUROPE ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS
8.1 OVERVIEW
8.2 STRESS TEST
8.3 BLOOD TEST
8.4 IMAGING
8.5 OTHERS
9 EUROPE ACUTE CORONARY SYNDROME MARKET, BY TREATMENT
9.1 OVERVIEW
9.2 MEDICATION
9.3 SURGERY
10 EUROPE ACUTE CORONARY SYNDROME MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS AND CLINICS
10.3 DIAGNOSTIC CENTERS
10.4 ACADEMIC INSTITUTES
10.5 OTHERS
11 EUROPE ACUTE CORONARY SYNDROME MARKET, BY REGION
11.1 EUROPE
11.1.1 GERMANY
11.1.2 FRANCE
11.1.3 U.K.
11.1.4 ITALY
11.1.5 RUSSIA
11.1.6 SPAIN
11.1.7 TURKEY
11.1.8 NETHERLANDS
11.1.9 SWITZERLAND
11.1.10 BELGIUM
11.1.11 REST OF EUROPE
12 EUROPE ACUTE CORONARY SYNDROME MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: EUROPE
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 NOVARTIS AG
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.1.5.1 PRODUCT EXPANSION
14.1.5.2 COLLABRATION
14.2 ASTRA ZENECA
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENT
14.2.5.1 ACQUISITION
14.3 AMGEN INC.
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 SANOFI
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
14.4.5.1 ACQUISITION
14.5 BAXTER
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 DR. REDDY’S LABORATORIES LTD.
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENTS
14.6.4.1 ACQUISTION
14.7 PFIZER INC.
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENT
14.8 MERCK & CO., INC.
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENTS
14.8.4.1 EVENT
14.8.4.2 ACQUISTION
14.9 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.9.3.1 PRODUCT APPROVAL
14.1 CSL
14.10.1 COMPANY SNAPSHOT
14.10.2 REVENUE ANALYSIS
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPMENT
14.10.4.1 ACQUISITION
14.11 DAIICHI SANKYO COMPANY,LIMITED
14.11.1 COMPANY SNAPSHOT
14.11.2 REVENUE ANALYSIS
14.11.3 PRODUCT PORTFOLIO
14.11.4 RECENT DEVELOPMENT
14.11.4.1 PARTNERSHIP
14.12 JOHNSON & JOHNSON SERVICES, INC.
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENT
14.12.4.1 ACQUISITION
14.13 TEVA PHARMACEUTICAL INDUSTRIES LTD.
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENT
14.13.4.1 ACQUISITION
14.14 REGENERON PHARMACEUTICALS INC.
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 LIST OF RECENT PROGRESS OF 3D BIO PRINTING FOR CARDIAC TISSUE ENGINEERING-
TABLE 2 EUROPE ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 3 EUROPE NON-ST-ELEVATION MYOCARDIAL INFARCTION IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 EUROPE ST—ELEVATION MYOCARDIAL INFARCTION IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 EUROPE UNSTABLE ANGINA IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 EUROPE ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)
TABLE 7 EUROPE STRESS TEST IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 EUROPE BLOOD TEST IN ACUTE SYNDROME CORONARY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 EUROPE IMAGING IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 EUROPE OTHERS IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 EUROPE ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 12 EUROPE MEDICATION IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 EUROPE SURGERY IN ACUTE CORONARY SYNDROME MARKET, BY REGION 2020-2029 (USD MILLION)
TABLE 14 EUROPE ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 15 EUROPE HOSPITALS AND CLINICS IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 EUROPE DIAGNOSTIC CENTERS IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 EUROPE ACADEMIC INSTITUTES IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 EUROPE OTHERS IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 EUROPE ACUTE CORONARY SYNDROME MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 20 EUROPE ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 21 EUROPE ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)
TABLE 22 EUROPE ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 23 EUROPE ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 24 GERMANY ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 25 GERMANY ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)
TABLE 26 GERMANY ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 27 GERMANY ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 28 FRANCE ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 29 FRANCE ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)
TABLE 30 FRANCE ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 31 FRANCE ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 32 U.K. ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 33 U.K. ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)
TABLE 34 U.K. ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 35 U.K. ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 36 ITALY ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 37 ITALY ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)
TABLE 38 ITALY ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 39 ITALY ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 40 RUSSIA ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 41 RUSSIA ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)
TABLE 42 RUSSIA ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 43 RUSSIA ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 44 SPAIN ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 45 SPAIN ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)
TABLE 46 SPAIN ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 47 SPAIN ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 48 TURKEY ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 49 TURKEY ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)
TABLE 50 TURKEY ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 51 TURKEY ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 52 NETHERLANDS ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 53 NETHERLANDS ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)
TABLE 54 NETHERLANDS ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 55 NETHERLANDS ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 56 SWITZERLAND ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 57 SWITZERLAND ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)
TABLE 58 SWITZERLAND ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 59 SWITZERLAND ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 60 BELGIUM ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 61 BELGIUM ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)
TABLE 62 BELGIUM ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 63 BELGIUM ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 64 REST OF EUROPE ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 EUROPE ACUTE CORONNARY SYNDROME MARKET: SEGMENTATION
FIGURE 2 EUROPE ACUTE CORONARY SYNDROME MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE ACUTE CORONARY SYNDROME MARKET: DROC ANALYSIS
FIGURE 4 EUROPE ACUTE CORONARY SYNDROME MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE ACUTE CORONARY SYNDROME MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE ACUTE CORONARY SYNDROME MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE ACUTE CORONARY SYNDROME MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE ACUTE CORONARY SYNDROME MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 9 EUROPE ACUTE CORONARY SYNDROME MARKET: SEGMENTATION
FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE THE EUROPE ACUTE CORONARY SYNDROME MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 11 RISING PREVALENCE OF CORONARY ARTERY DISEASE, ISCHEMIC HEART AND VASCULAR DISEASE AS WELL AS GROWING GERIATRIC POPULATION IS DRIVING THE EUROPE ACUTE CORONARY SYNDROME MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE ACUTE CORONARY SYNDROME MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE ACUTE CORONARY SYNDROME MARKET
FIGURE 14 EUROPE ACUTE CORONARY SYNDROME MARKET: BY TYPE, 2021
FIGURE 15 EUROPE ACUTE CORONARY SYNDROME MARKET: BY TYPE, 2022-2029 (USD MILLION)
FIGURE 16 EUROPE ACUTE CORONARY SYNDROME MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 17 EUROPE ACUTE CORONARY SYNDROME MARKET: BY TYPE, LIFELINE CURVE
FIGURE 18 EUROPE ACUTE CORONARY SYNDROME MARKET: BY DIAGNOSIS, 2021
FIGURE 19 EUROPE ACUTE CORONARY SYNDROME MARKET: BY DIAGNOSIS, 2022-2029 (USD MILLION)
FIGURE 20 EUROPE ACUTE CORONARY SYNDROME MARKET: BY DIAGNOSIS, CAGR (2022-2029)
FIGURE 21 EUROPE ACUTE CORONARY SYNDROME MARKET: BY DIAGNOSIS, LIFELINE CURVE
FIGURE 22 EUROPE ACUTE CORONARY SYNDROME MARKET: BY TREATMENT, 2021
FIGURE 23 EUROPE ACUTE CORONARY SYNDROME MARKET: BY TREATMENT, 2022-2029 (USD MILLION)
FIGURE 24 EUROPE ACUTE CORONARY SYNDROME MARKET: BY TREATMENT, CAGR (2022-2029)
FIGURE 25 EUROPE ACUTE CORONARY SYNDROME MARKET: BY TREATMENT, LIFELINE CURVE
FIGURE 26 EUROPE ACUTE CORONARY SYNDROME MARKET: BY END USER, 2021
FIGURE 27 EUROPE ACUTE CORONARY SYNDROME MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 28 EUROPE ACUTE CORONARY SYNDROME MARKET: BY END USER, CAGR (2022-2029)
FIGURE 29 EUROPE ACUTE CORONARY SYNDROME MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 EUROPE ACUTE CORONARY SYNDROME MARKET: SNAPSHOT (2021)
FIGURE 31 EUROPE ACUTE CORONARY SYNDROME MARKET: BY COUNTRY (2021)
FIGURE 32 EUROPE ACUTE CORONARY SYNDROME MARKET: BY COUNTRY (2022 & 2029)
FIGURE 33 EUROPE ACUTE CORONARY SYNDROME MARKET: BY COUNTRY (2021 & 2029)
FIGURE 34 EUROPE ACUTE CORONARY SYNDROME MARKET: BY TYPE (2022-2029)
FIGURE 35 EUROPE ACUTE CORONARY SYNDROME MARKET: COMPANY SHARE 2021 (%)
